Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.2K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

579
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
579
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

592
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
592
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.7K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.7K
Antibiotic Selection00:57

Antibiotic Selection

56.7K
Overview
56.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Acting Lipoglycopeptide Treatment of Invasive Gram-Positive Infections.

Drugs·2026
Same author

Using the Damage Response Framework as a Lens to Discuss Acinetobacter baumannii Host-Pathogen Interactions: A Narrative Review and a Call to Action.

Infectious diseases and therapy·2026
Same author

Assessment of treatment outcomes in patients receiving high- versus low-dose sulfamethoxazole-trimethoprim for oral stepdown therapy in gram-negative bacteremia: a multi-center, retrospective cohort study.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Impact of early vs delayed initiation of dual antimicrobial salvage therapy on clinical outcomes in MRSA bacteremia.

Microbiology spectrum·2026
Same author

Structure, personnel, and initiatives of antimicrobial stewardship programs in pediatric hospitals in the United States based on on-call participation: a cross-sectional survey.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Management of Gram-Negative Bloodstream Infections With Oral Antibiotics in Solid Organ Transplant Recipients.

Clinical transplantation·2026

Related Experiment Video

Updated: Oct 24, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

803

Exebacase in Addition to Daptomycin against MRSA.

Razieh Kebriaei1, Kyle C Stamper1, Katherine L Lev1

  • 1Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.

Antimicrobial Agents and Chemotherapy
|August 16, 2021
PubMed
Summary

Exebacase, a novel lysin, demonstrates potent bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA). When combined with daptomycin in an ex vivo model, exebacase significantly reduced MRSA bacterial load.

Keywords:
S. aureusdaptomycinexebacase

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.2K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.8K

Related Experiment Videos

Last Updated: Oct 24, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

803
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.2K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.8K

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Staphylococcus aureus, including MRSA, poses a significant threat due to its resistance to conventional antibiotics.
  • Lysins, such as exebacase, are enzymes with direct lytic activity against bacterial cell walls.
  • Novel therapeutic strategies are urgently needed to combat MRSA infections.

Purpose of the Study:

  • To evaluate the direct lytic activity of exebacase against Staphylococcus aureus, including MRSA.
  • To assess the combined efficacy of exebacase and daptomycin against MRSA in vitro and ex vivo.
  • To determine the pharmacokinetic/pharmacodynamic profile of exebacase-daptomycin combination therapy.

Main Methods:

  • Time-kill kinetic assays were performed to evaluate bactericidal activity.
  • A two-compartment ex vivo pharmacokinetic/pharmacodynamic model simulating endocardial vegetation was utilized.
  • Humanized doses of exebacase in combination with daptomycin were tested against MRSA strains.

Main Results:

  • Exebacase exhibited direct lytic activity against Staphylococcus aureus and MRSA strains.
  • The combination of exebacase and daptomycin showed significant bactericidal activity in time-kill experiments.
  • Ex vivo studies demonstrated substantial reductions in MRSA load (up to 6.01 log10 CFU/g) with exebacase-daptomycin treatment at various doses.

Conclusions:

  • Exebacase is a promising therapeutic agent with direct bactericidal effects against MRSA.
  • The combination of exebacase and daptomycin exhibits synergistic activity, offering a potential new treatment for MRSA infections.
  • Further clinical investigation of exebacase-daptomycin is warranted.